← All organizations
Highest phase reached
Phase 2
First clinical trial
May 1, 1999Last known activity
Sep 30, 2024
Timeline
1970s
- Jan 1, 1971
Ludwig Institute for Cancer Research— Founded
Drugs by trial phase (77 distinct, 60 trials)
Phase 2 (36 own, 0 via acquisition)
Phase 1 (38 own, 0 via acquisition)
Indications
Studied for
- Appendiceal Neoplasms
- Carcinoma
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Transitional Cell
- Colorectal Neoplasms
- Fallopian Tube Neoplasms
- Gastrointestinal Stromal Tumors
- Glioblastoma
- Kidney Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Melanoma
- Multiple Myeloma
- Neoplasms
- Neoplasms, Plasma Cell
- Ovarian Neoplasms
- Peritoneal Neoplasms
- Prostatic Neoplasms
- Recurrence
- Sarcoma
- Sarcoma, Synovial
- Skin Neoplasms
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Testicular Neoplasms
- Urinary Bladder Neoplasms
Recent trials (50)
- NCT06518837CollaboratorPhase 2Sep 30, 2024
- NCT05736367CollaboratorN/AOct 15, 2023
- NCT04729543CollaboratorPhase 1/Phase 2Oct 20, 2020
- NCT03164772Lead sponsorPhase 1/Phase 2Jul 1, 2017
- NCT02898116Lead sponsorPhase 1/Phase 2Mar 1, 2017
- NCT02963831Lead sponsorPhase 1/Phase 2Jan 1, 2017
- NCT02643303Lead sponsorPhase 1/Phase 2Dec 28, 2016
- NCT02716805Lead sponsorPhase 1Nov 1, 2016
- NCT02659540Lead sponsorPhase 1Jul 1, 2016
- NCT02735239Lead sponsorPhase 1/Phase 2Jun 1, 2016
- NCT02431559Lead sponsorPhase 1/Phase 2Nov 1, 2015
- NCT02334735CollaboratorPhase 2Jul 1, 2015
- NCT02425306CollaboratorPhase 1/Phase 2May 1, 2015
- NCT02336165Lead sponsorPhase 2Feb 26, 2015
- NCT02252211Lead sponsorPhase 1Sep 1, 2014
Details
- Founded
- Zurich, CH Jan 1, 1971
- Last known activity
- Sep 30, 2024